Luye Pharma Group Ltd. (HKG:2186)

Luye Pharma Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,375	8,163	14,031	12,992	12,607	11,729
Market Cap Growth	-41.82%	-41.82%	8.00%	3.05%	7.49%	-38.56%
Enterprise Value	20,139	12,502	17,078	18,013	16,610	16,596
Last Close Price	3.80	2.17	3.73	3.66	3.56	3.61
PE Ratio	28.48	16.26	23.91	19.00	-	13.98
Forward PE	23.10	8.49	17.57	17.45	8.01	6.62
PS Ratio	2.23	1.26	2.07	1.92	1.98	1.78
PB Ratio	0.86	0.49	0.94	1.04	1.13	1.22
P/TBV Ratio	1.76	1.00	1.91	2.43	3.00	3.22
P/FCF Ratio	-	-	13.23	11.51	-	28.99
P/OCF Ratio	80.52	45.72	7.98	6.95	56.32	9.56
PEG Ratio	-	0.84	0.84	0.84	0.84	0.84
EV/Sales Ratio	3.12	1.94	2.52	2.66	2.60	2.52
EV/EBITDA Ratio	9.86	6.21	9.98	11.18	14.92	9.53
EV/EBIT Ratio	16.66	10.34	17.47	20.19	37.24	14.14
EV/FCF Ratio	-44.39	-	16.10	15.96	-	41.02
Debt / Equity Ratio	0.66	0.66	0.62	0.83	1.04	1.23
Debt / EBITDA Ratio	5.38	5.38	5.33	6.27	10.09	6.68
Debt / FCF Ratio	-	-	8.75	9.12	-	29.30
Asset Turnover	0.22	0.22	0.25	0.26	0.24	0.28
Inventory Turnover	2.32	2.32	2.42	2.42	2.66	2.52
Quick Ratio	1.01	1.01	1.08	0.83	1.08	1.00
Current Ratio	1.24	1.24	1.32	1.14	1.42	1.38
Return on Equity (ROE)	4.41%	4.41%	4.39%	5.79%	-1.68%	8.26%
Return on Assets (ROA)	2.58%	2.58%	2.23%	2.11%	1.05%	3.09%
Return on Capital (ROIC)	2.96%	2.96%	2.63%	2.55%	1.24%	3.48%
Return on Capital Employed (ROCE)	6.00%	6.00%	5.10%	5.30%	2.40%	7.40%
Earnings Yield	3.49%	6.15%	4.18%	5.26%	-1.31%	7.16%
FCF Yield	-3.16%	-5.56%	7.56%	8.69%	-3.64%	3.45%
Payout Ratio	-	-	-	-	-	24.84%
Buyback Yield / Dilution	-0.89%	-0.89%	-7.11%	-1.03%	-7.87%	0.85%
Total Shareholder Return	-0.89%	-0.89%	-7.11%	-1.03%	-7.87%	0.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.